Antiparasitic prophylaxis (except toxoplasmosis) in immunocompromised patients;Prophylaxie des infections parasitaires (toxoplasmose exclue) chez les patients immunodeprimes

Annales de Medecine Interne

Volumn 148, Issue 3, 1997, Pages 240-245

  Hennequin, Christophe ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Leishmaniosis; Pneumocystis carinii; Prophylaxis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIPARASITIC AGENT; COTRIMOXAZOLE; PENTAMIDINE;

BLOOD DISEASE; CELLULAR IMMUNODEFICIENCY; COMBINED IMMUNODEFICIENCY; CRYPTOSPORIDIOSIS; DRUG EFFICACY; HEART LUNG TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; KIDNEY TRANSPLANTATION; LEISHMANIASIS; LYMPHOCYTE COUNT; MICROSPORIDIOSIS; PARASITOSIS; PNEUMOCYSTIS PNEUMONIA; PROPHYLAXIS; RASH; REVIEW;

ANIMALS; CRYPTOSPORIDIOSIS; HUMANS; IMMUNOCOMPROMISED HOST; LEISHMANIASIS; MICROSPORIDIOSIS; PARASITIC DISEASES; PNEUMOCYSTIS INFECTIONS;

EID: 0030841789     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. WALZER P : Pneumocystis carinii-new clinical spectrum ? N Engl J Med 1991 ; 324 : 263-5.
2. HENNEQUIN C, PAGE B, Roux P, LEGENDRE C, KREIS H : Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit. Eur J Clin Microbiol Infect Dis 1995 ; 14 : 122-6.
3. BLUM RN, MILLER LA, GAGGINI LC, COHN DL : Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia. J AIDS 1992 ; 5 : 341-7.
4. MALLOLAS J, ZAMORA L, GATTEL JM et al : Primary prophylaxis for Pneumocystis carinii pneumonia : a randomized trial comparing TMP-SMX, aerosolized pentamidine and dapsone plus pyrimethamine. AIDS 1993 ; 7 : 59-64.
5. PODZAMCZER D, SANTIN M, JIMENEZ J et al : Thrice-weekly TMP-SMX is better than weekly dapsone-pyrethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients. AIDS 1993 ; 7 : 501-6.
6. MAY T, BEUSCART C, REYNES J et. al : Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia : a prospective, randomized, controlled clinical trial. J AIDS 1994 ; 7 : 457-62.
7. BOZZETTE SA, FINKELSTEIN DM, SPECTOR SA et al : A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995 ; 332 : 693-9.
8. HARDY WD, FEINBERG J, FINKELSTEIN DM et al : A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992 ; 327 : 1842-8.
9. SCHNEIDER MM, HOEPELMAN AI, EEFTINCK SCHATTENKERK JK et al : A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992; 327 : 1836-41.
10. JLNG AC, PAAUW DS : Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Arch Intern Med 1994 ; 154 : 2402-6.
11. OKSENHENDLER E, CHARREAU I, TOURNERIE C et al : Toxoplasma gondii infection in advanced HIV infection. AIDS 1994; 8 : 483-7.
12. MONTANER JSG, LAWSON LM, GERVAIS A et al : Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumoniae. A randomized, placebo-controlled study. Ann Intern Med 1991 ; 114 : 948-53.
13. GIRARD PM, LANDMAN R, GAUDEBOUT C et al : Dapsonepyrimethamine compared with aerolized pentamine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HTV-infection. N Engl J Med 1993 ; 328: 1514-20.
14. OPRAVIL M, HIRSHEL B, LAZZARIN A et al : Once-weekly administration of dapsone/pyrimethamine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin Infect Dis 1995 ; 20 : 531-41.
15. COKER RJ, NIEMAN R, MCBRIDE M et al : Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia. Lancet 1992 ; 340 : 1099.
16. JORDE UP, HOROWITZ HW, WORMSER GP. Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole intolerant HIV-infected individuals. AIDS 1993 ; 7 : 355-9.
17. CLUMECK N : Primary prophylaxis against opportunistic infections in patients with AIDS. N Engl J Med 1995 ; 332 : 739-40.
18. SEPKOWITZ KA : Pneumocystis carinii pneumoniae in patients without AIDS. Clin infect Dis 1993 ; 17 : 416-22.
19. HUGHES WT, KUHN S, CHAUDHARY S et al : Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977 ; 297 : 1419-26.
20. MEYERS JD, PIFER LL, SALE GE, THOMAS ED : The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumoniae after marrow transplantation. Am Rev Respir Dis 1979 ; 120 : 1283-7.
21. LEGGIADRO RJ, WINKELSTEIN JA, HUGHES WT : Prevalence of Pneumocystis carinii pneumonitis in severe combined immunodeficiency. J Pediatr 1981 ; 99 : 96-8.
22. KRAMER MR, STOEHR C, LEWISTON NJ et al : Trimethoprimsulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation-how effective and for how long ? Transplantation 1992 ; 53 : 586-9.
23. BENSOUSAN T, GARO B, GARRE B et al : La numération des lymphocytes CD4 permet-elle de prévoir la survenue des pneumonies après transplantation rénale ? Méd Mal Infect 1993 : 23 : 261-3.
24. HUGHES WT, RIVERA GK, SCHELL MJ et al : Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1987 ; 316 : 1627-35.
25. MARTY P, LE FICHOUX Y, PRATLONG F, GARI-TOUSSAINT M : Human visceral leishmaniasis in Alpes-Maritimes, France : epidemiological characteristics for the period 1985-1992. Trans R Soc Trop Med Hyg 1994 ; 88 : 33-4.
26. MONTALBAN C, CALLEJA JL, ERICE A et al : Visceral leishmaniasis in patients infected with human immunodeficiency virus. J Infec 1990 ; 21 : 261-70.
27. PETTERS B, FISH D, GOLDEN R et al : Visceral leishmaniasis in HIV infection and AIDS : clinical features and response to therapy. Q J Med 1990 ; 77 : 1101-11.
28. GAZAPO E, LAGUNA F, MARTINEZ P et al : Visceral leishmaniasis in HIV patients (abstract). In : Program and Abstracts of VIIth International Conference on AIDS, Amsterdam, The Nederlands, 1992.
29. MATHERON S, CABIE F, PARQUIN C et al : Visceral leishmaniasis and HIV infection : unusual presentation with pleuropulmonary involvement, and effect of secondary prophylaxis. AIDS 1992 ; 6 : 238-40.
30. LAFEUILLADE A, CHAFFANJON P, DELBEKE E et al : Maintenance itraconazole for visceral leishmaniasis in HIV infection. Am J Med 1992 ; 92 : 449.
31. DAVIDSON RN, DI MARTINO L, GRADONI L et al : Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis : a multi centre trial. Q J Med 1994 ; 87 : 75-81.
32. DAVIDSON RN, Russo R : Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin. Clin Infect Dis 1994 ; 19 : 560.
33. TORRE-CISNEROS J, VILLANUEVA JL, PRADA JL, KINDELAN JM, JURADO R, SANCHEZ-GUIJO R : Liposomal-amphotericin B in the treatment of antimonial-resistant visceral leishmaniasis in patients infected with human immunodeficiency virus (abstract 1082). In : Progam and Abstracts of the 33rd Interscience Conference on Antibiomicrobial Agents and Chemotherapy, Washington, DC, 1993.
34. TORRE-CISNEROS J, VILLANUEVA JL, KINDELAN JM : Successfull treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus. Clin Infect Dis 1993 ; 17 : 625-627.
35. LAUGHON BE, DRUCKMAN DA, VERNON A et al : Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology 1988 ; 94 : 984-93.
36. RAVN P, LUNDGREN JD, KJAELGAARDD P et al : Nosocomial outbreak of cryptosporidiosis in AIDS patients. Br Med J 1991 ; 302 : 277-9.
37. GATHE JJR, PIOT D, BERNAL A, CLEMMONS J, STOOL E : Treatment of gastrointestinal cryptosporidiosis (abstract MB2270). In : Progam and Abstracts of the 7th International Conference on AIDS, Rome, Italy, 1991.
38. REHG JE : Activity of azithromycin against cryptosporidia in immunosuppresed rats. J Infect Dis 1993 ; 163 : 1293-6.
39. SOAVE R, HAVLIR D, LANCASTER D et al : Azythromycin therapy of AIDS related cryptosporidial diarrhea : a multi-center, placebo-controlled, double-blind study (abstract 405). In : Progam and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, USA, 1993.
40. RITCHIE DJ, BECKER ES : Update on the management of intestinal crytosporidiosis in AIDS. Ann Pharmacother 1994 ; 28 : 767-78.
41. WEBER R, BRYAN RT : Microsporidial infections in immunodeficient and immunocompetent patients. Clin Infect Dis 1994 ; 19 : 517-21.
42. MOLINA JM, OKSENHENDLER E, BEAUVAIS B : Disseminated microsporidiosis due to Septata intestinalis in patients with AIDS : clinical features and response to albendazole therapy. J Infect Dis 1995 ; 171 : 245-59.
43. ALVAR J, GUTTIEREZ-SOLAR B, MOLINA R et al : Prevalence of Leishmania infection among AIDS patients. Lancet 1992 ; 339 : 1427.
44. HING M, HARKNKSS J, VERRE J, FIELD A, MARRIOTT D : Enteric microsporidiasis-response to azithromycin therapy (abstract). In : Progam and Abstracts of Workshop on Intestinal Microsporidia in HIV Infection, Paris, 1992.